Schedule 13G ownership disclosure

CAMP4 Therapeutics Corp.

Common Stock · CUSIP: 13463J101

Event date: 2025-12-31

Filing-level shares
6,307,636
Percent of class
12.2%
  • JANUS HENDERSON GROUP PLC

    Shares: 6,307,636 · Class: 12.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001274173-26-000026
Form type
SCHEDULE 13G
Filer
Camp4 Therapeutics Corp
CIK
CIK 1736730
Filed
Jan 08, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub